ALS, orodispersible riluzole formulation available in Italy. A thin film to be dissolved over the tongue, without the need for water or muscular effort, will help those living with Amyotrophic Lateral Sclerosis.
Currently, over 1 in 2 patients with dysphagia crush their tablets in order to swallow them, a practice that can lead to taking up to 42% less active ingredient, seriously compromising the effectiveness of the therapy. In our country, Amyotrophic Sclerosis (ALS) affects more than 6,000 people and 2,000 new cases are registered every year.